Skip to main content
. Author manuscript; available in PMC: 2016 Jul 21.
Published in final edited form as: Curr Opin Urol. 2016 May;26(3):231–239. doi: 10.1097/MOU.0000000000000278

FIGURE 1.

FIGURE 1

Precision medicine in advanced prostate cancer revolves around the ability to take a tumor sample, ideally metastatic tumor, sequence the tumor, and assign therapy to the patient. This involves biopsy of tumor tissue, DNA/RNA extraction, WES/WGS/Transcriptome sequencing, bioinformatics interpretation of results, and assignment of treatment based on therapeutic profile. This process may be repeated as needed when patients progress. WES, whole-exome sequencing; WGS, whole genome sequencing.